ArticleJournal of animal science and biotechnology2026
Fisetin alleviates zinc overload-induced intestinal injury by inhibiting ferroptosis and remodeling gut microbiota in weaned piglets.
Article in Journal of animal science and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundHigh doses of zinc oxide (ZnO) effectively prevent post-weaning diarrhea and promote growth in weaned piglets, but raise concerns over intestinal injury, metabolic disorders, and risks of fostering bacterial resistance. This study aimed to identify non-chelating polyphenols capable of mitigating zinc toxicity and to elucidate their protective mechanisms, with emphasis on ferroptosis inhibition.
resultsNetwork toxicology predicted ferroptosis as a central mechanism in zinc-induced intestinal injury, which was confirmed in intestinal epithelial cells where zinc overload specifically induced ferroptosis without activating apoptosis, necroptosis, or autophagy. From multiple polyphenols, fisetin (FIS) was identified as a non-chelating candidate that alleviated zinc-induced cytotoxicity, preserved tight junction proteins, and activated the Nrf2-GPX4 axis to inhibit ferroptosis in vitro. In zinc-overloaded weaned piglets, FIS supplementation maintained the growth-promoting effects of high-dose zinc while ameliorating intestinal damage. FIS also attenuated oxidative stress, alleviated inflammation, and inhibited ferroptosis in the jejunum. Furthermore, FIS remodeled the gut microbiota, enriching beneficial taxa Romboutsia (positively correlated with growth performance) and Clostridium_sensu_stricto_1 (positively correlated with the p-Nrf2/Nrf2 ratio), while suppressing the zinc-enriched Anaerovibrio (negatively correlated with GPX4 protein expression). FIS also shifted microbial metabolic pathways toward amino acid and terpenoid metabolism, potentially contributing to the observed ferroptosis defense.
conclusionFIS alleviates high-dose ZnO-induced intestinal injury in weaned piglets through dual modulation, activating the Nrf2-GPX4 axis to inhibit ferroptosis and remodeling the gut microbiota to reinforce this defense. By preserving the growth benefits of zinc while mitigating its toxicity, FIS represents a promising nutritional strategy for sustainable swine production.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.